Status: Not yet recruiting
Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
The goal of this research study is to evaluate the efficacy and safety of low-dose exemestane versus low-dose tamoxifen in post-menopausal women at high risk for breast cancer. The names of the study drugs involved in this study are: * Exemestane (a type of steroidal aromatase inhibitor) * Tamoxifen (a type of selective estrogen receptor modulator)
Participants needed: 140
Trial details
Phase: Phase 2Biological sex: FemaleType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: Mar 30, 2026Locations: 2
Eligibility criteria
Postmenopausal state is defined⁸ as no menses for 12 months without an alternati... [+12]
Pre/perimenopausal women: exemestane is only effective in post-menopausal women [+15]